In Gurugram, Haryana, India, authorities have dismantled a counterfeit drug operation producing fake Mounjaro (tirzepatide) injections, which are used for treating diabetes and obesity. The operation was uncovered following a raid that resulted in the seizure of counterfeit products valued at ₹70 lakh (approximately $84,000 USD) and the arrest of two suspects, including the alleged kingpin, Avi Sharma. The counterfeit injections were reportedly manufactured in a flat where raw drugs imported from China were mixed with water. Eli Lilly, the manufacturer of Mounjaro, has responded to the situation by expressing its commitment to patient safety and supporting regulatory actions against illicit medicines. A nationwide alert has been issued to help health authorities identify and trace counterfeit batches, ensuring that patients remain protected from unsafe products. Investigations are ongoing to uncover the full extent of the network behind this illegal operation.